Search Results - "Schambye, H T"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    Transcriptome analysis of FSH and FSH variant stimulation in granulosa cells from IVM patients reveals novel regulated genes by Perlman, S., Bouquin, T., van den Hazel, B., Jensen, T.H., Schambye, H.T., Knudsen, S., Okkels, J.S.

    Published in Molecular human reproduction (01-03-2006)
    “…FSH is crucial for oocyte maturation and fertility and is the main component in infertility treatment in assisted reproduction. The granulosa cells expressing…”
    Get full text
    Journal Article
  2. 2

    Differentiation Between Binding Sites for Angiotensin II and Nonpeptide Antagonists on the Angiotensin II Type 1 Receptors by Schambye, Hans T., Hjorth, Siv A., Bergsma, Derk J., Sathe, Ganesh, Schwartz, Thue W.

    “…To characterize binding sites for nonpeptide angiotensin antagonists on the human angiotensin II receptor type 1 (AT1receptor) we have systematically exchanged…”
    Get full text
    Journal Article
  3. 3

    Identification of peptide binding residues in the extracellular domains of the AT1 receptor by Hjorth, S A, Schambye, H T, Greenlee, W J, Schwartz, T W

    Published in The Journal of biological chemistry (09-12-1994)
    “…To locate essential determinants for angiotensin II binding, we have performed a systematic mutational analysis of the exterior domain of the AT1 receptor…”
    Get full text
    Journal Article
  4. 4

    Interaction between the nonpeptide angiotensin antagonist SKF-108,566 and histidine 256 (HisVI:16) of the angiotensin type 1 receptor by Schambye, H T, Hjorth, S A, Weinstock, J, Schwartz, T W

    Published in Molecular pharmacology (01-03-1995)
    “…His256 (HisVI:16) of transmembrane segment (TM)-VI of the rat angiotensin type 1 (AT1) receptor was targeted for mutagenesis to investigate its potential…”
    Get more information
    Journal Article
  5. 5

    Bicarbonate- versus lactate-based CAPD fluids: a biocompatibility study in rabbits by Schambye, H T, Flesner, P, Pedersen, R B, Hardt-Madsen, M, Chemnitz, J, Christensen, H K, Detmer, A, Pedersen, F B

    Published in Peritoneal dialysis international (1992)
    “…Previous in vitro biocompatibility studies have shown bicarbonate-based continuous ambulatory peritoneal dialysis (CAPD) fluids to be superior to those based…”
    Get more information
    Journal Article
  6. 6

    The cytotoxicity of continuous ambulatory peritoneal dialysis solutions with different bicarbonate/lactate ratios by Schambye, H T, Pedersen, F B, Christensen, H K, Berthelsen, H, Wang, P

    Published in Peritoneal dialysis international (1993)
    “…Five different bicarbonate-based continuous ambulatory peritoneal dialysis (CAPD) solutions (pH: 7.0-7.4; bicarbonate: 10-27 mM; lactate: 20.8-6.7 mM) were…”
    Get more information
    Journal Article
  7. 7

    Effect of different buffers on the biocompatibility of CAPD solutions by Schambye, H T

    Published in Peritoneal dialysis international (1996)
    “…Commercially available solutions for continuous ambulatory peritoneal dialysis (CAPD) affect the viability and function of the cells in the peritoneal cavity…”
    Get more information
    Journal Article
  8. 8

    Bicarbonate is not the ultimate answer to the biocompatibility problems of CAPD solutions: a cytotoxicity test of CAPD solutions and effluents by Schambye, H T, Pedersen, F B, Wang, P

    Published in Advances in peritoneal dialysis (1992)
    “…Human polymorphonuclear granulocytes (PMN) were tested for migration and phagocytosis after exposure to CAPD solutions and effluents sampled during the first…”
    Get full text
    Journal Article
  9. 9

    Mutations in transmembrane segment VII of the AT1 receptor differentiate between closely related insurmountable and competitive angiotensin antagonists by SCHAMBYE, H. T, WIJK, B. V, HJORTH, S. A, WIENEN, W, ENTZEROTH, M, BERGSMA, D. J, SCHWARTZ, T. W

    Published in British journal of pharmacology (01-10-1994)
    “…Chimeric constructs between the human and the Xenopus laevis AT1 receptor have demonstrated, that the binding of non-peptide angiotensin antagonists is…”
    Get full text
    Journal Article
  10. 10

    Non-peptide angiotensin agonist. Functional and molecular interaction with the AT1 receptor by Perlman, S, Schambye, H T, Rivero, R A, Greenlee, W J, Hjorth, S A, Schwartz, T W

    Published in The Journal of biological chemistry (27-01-1995)
    “…Non-peptide ligands for peptide receptors for the G-protein-coupled type are generally antagonists, except in the opiate system. Recently, it was observed that…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Dual agonistic and antagonistic property of nonpeptide angiotensin AT1 ligands: susceptibility to receptor mutations by Perlman, S, Costa-Neto, C M, Miyakawa, A A, Schambye, H T, Hjorth, S A, Paiva, A C, Rivero, R A, Greenlee, W J, Schwartz, T W

    Published in Molecular pharmacology (01-02-1997)
    “…Two nonpeptide ligands that differ chemically by only a single methyl group but have agonistic (L-162,782) and antagonistic (L-162,389) properties in vivo were…”
    Get more information
    Journal Article
  13. 13

    Mutations in transmembrane segment VII of the AT sub(1) receptor differentiate between closely related insurmountable and competitive angiotensin antagonists by Schambye, H T, Wijk, B V, Hjorth, SA, Wienen, W, Entzeroth, M, Bergsma, D J, Schwartz, T W

    Published in British journal of pharmacology (01-01-1994)
    “…Chimeric constructs between the human and the Xenopus laevis AT sub(1) receptor have demonstrated, that the binding of non-peptide angiotensin antagonists is…”
    Get full text
    Journal Article
  14. 14

    Non-peptide antagonists to angiotensin II receptors. A review by Schambye, H T, Hjorth, S A, Schwartz, T W

    Published in Ugeskrift for læger (01-11-1993)
    “…The renin-angiotensin system is the most important hormone system in the control of blood pressure and electrolyte homeostasis. Pharmacological blockade of the…”
    Get more information
    Journal Article